Arumugam P, George R, Jayaseelan VP (2021) Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma. Arch Oral Biol 122:105030. https://doi.org/10.1016/j.archoralbio.2020.105030

Article  CAS  PubMed  Google Scholar 

Botha H, Farah CS, Koo K, Cirillo N, McCullough M, Paolini R, Celentano A (2021) The role of glucose transporters in oral squamous cell carcinoma. Biomolecules. https://doi.org/10.3390/biom11081070

Article  PubMed  PubMed Central  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492

Article  PubMed  Google Scholar 

Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL, Wong CM (2018) RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology. 67(6):2254–2270. https://doi.org/10.1002/hep.29683

Article  CAS  PubMed  Google Scholar 

Chen X, Lu T, Cai Y, Han Y, Ding M, Chu Y, Wang X (2023) KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo-YAP pathway. Cell Mol Biol Lett 28(1):32. https://doi.org/10.1186/s11658-023-00445-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chien MH, Yang JS, Chu YH, Lin CH, Wei LH, Yang SF, Lin CW (2012) Impacts of CA9 gene polymorphisms and environmental factors on oral-cancer susceptibility and clinicopathologic characteristics in Taiwan. PLoS ONE 7(12):e51051. https://doi.org/10.1371/journal.pone.0051051

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Zhan L (2022) Network pharmacology identifies therapeutic targets and the mechanisms of glutathione action in ferroptosis occurring in oral cancer. Front Pharmacol 13:851540. https://doi.org/10.3389/fphar.2022.851540

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumari R, Ranjan P, Suleiman ZG, Goswami SK, Li J, Prasad R, Verma SK (2022) mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification. Cardiovasc Res 118(7):1680–1692. https://doi.org/10.1093/cvr/cvab160

Article  CAS  PubMed  Google Scholar 

Lan T, Li H, Zhang D, Xu L, Liu H, Hao X, Wu H (2019) KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 18(1):186. https://doi.org/10.1186/s12943-019-1106-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lindemann A, Takahashi H, Patel AA, Osman AA, Myers JN (2018) Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res 97(6):635–644. https://doi.org/10.1177/0022034518759068

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Ren D, Du Z, Wang H, Zhang H, Jin Y (2018) m(6)A demethylase FTO facilitates tumor progression in lung squamous cell carcinoma by regulating MZF1 expression. Biochem Biophys Res Commun 502(4):456–464. https://doi.org/10.1016/j.bbrc.2018.05.175

Article  CAS  PubMed  Google Scholar 

Liu T, Wei Q, Jin J, Luo Q, Liu Y, Yang Y, Yi P (2020) The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucl Acids Res 48(7):3816–3831. https://doi.org/10.1093/nar/gkaa048

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo J, Wang X, Chen Z, Zhou H, Xiao Y (2023) The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma. J Bone Oncol 39:100471. https://doi.org/10.1016/j.jbo.2023.100471

Article  PubMed  PubMed Central  Google Scholar 

Mirghani H, Amen F, Moreau F, St Guily JL (2015) Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral Oncol 51(3):229–236. https://doi.org/10.1016/j.oraloncology.2014.11.011

Article  CAS  PubMed  Google Scholar 

Paramasivam A, George R, Priyadharsini JV (2021) Genomic and transcriptomic alterations in m6A regulatory genes are associated with tumorigenesis and poor prognosis in head and neck squamous cell carcinoma. Am J Cancer Res 11(7):3688–3697

CAS  PubMed  PubMed Central  Google Scholar 

Roundtree IA, Evans ME, Pan T, He C (2017) Dynamic RNA modifications in gene expression regulation. Cell 169(7):1187–1200. https://doi.org/10.1016/j.cell.2017.05.045

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su Z, Xu L, Dai X, Zhu M, Chen X, Li Y, Wang Y (2022) Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis. Aging (Albany NY) 14(21):8818–8838. https://doi.org/10.18632/aging.204371

Article  CAS  PubMed  Google Scholar 

Sun T, Wu R, Ming L (2019) The role of m6A RNA methylation in cancer. Biomed Pharmacother 112:108613. https://doi.org/10.1016/j.biopha.2019.108613

Article  CAS  PubMed  Google Scholar 

Wu Y, Wang Z, Han L, Guo Z, Yan B, Guo L, Zhang J (2022) PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer. Mol Ther 30(7):2603–2617. https://doi.org/10.1016/j.ymthe.2022.03.003

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Zhang L (2021) Recent advances of m(6)A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int 21(1):421. https://doi.org/10.1186/s12935-021-02132-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang X, Dai XY, Qian JY, Xu F, Wang ZW, Xia T, Ding Q (2022) SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer. Mol Ther Nucleic Acids 27:133–146. https://doi.org/10.1016/j.omtn.2021.08.009

Article  CAS  PubMed  Google Scholar